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Abstract  
 
Immunizations are one of the most important developments in the twentieth century 
towards the prevention of infectious diseases. Vaccinations against communicable diseases have 
helped reduce morbidity and mortality all over the world. Despite having numerous vaccines that 
protect individuals from serious and deadly diseases, vaccination rates in the United States 
remain at an all-time low. The Information and Education section of the Immunization Branch 
within the Division of Communicable Disease Control at the California Department of Public 
Health (CDPH) focuses on working with local health departments, primary care providers, 
immunization coalitions, and other statewide organizations to increase the rates of vaccinations 
in the United States. The Information and Education section aims to address vaccination 
disparities in the state of California. The main reasons parents and guardians opt out of fully 
vaccinating their children are due to personal belief exemptions (PBEs), concerns regarding 
vaccine-related side effects, and low provider recommendation. The Information and Education 
section is in charge of creating statewide campaigns and educational materials to help increase 
immunization rates. Four goals were developed for this fieldwork experience: general 
familiarization with the Immunization Branch; participate in the planning of Preteen Vaccine 
Week Campaign 2015, an immunization informing campaign; conduct impact evaluation and 
education material; and participate in maintenance of other immunization informing campaigns. 
The following paper is a summary of a 300-hour fieldwork experience at the CDPH to help 
increase awareness of vaccine-preventable diseases and the importance of being fully immunized 
through the development of informational and educational materials.  
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 The increase in life expectancy in the twentieth century is predominantly due to the 
development of vaccinations. Vaccines have helped reduce mortality and disability due to 
infectious disease. Even though vaccinations go through numerous research and study trials, 
vaccination rates remain low (United States Department of Health and Human Services [HHS], 
Healthy People 2020, 2014). People in the United States continue getting diseases that are 
vaccine preventable. 
 Roughly speaking, 42,000 adults and 300 children die in the United States annually from 
vaccine-preventable diseases (Centers for Disease Control and Prevention [CDC], 1999). 
Communities with unvaccinated and under-vaccinated residents are at greater risks for outbreaks 
of vaccine-preventable diseases (HHS, Healthy People 2020, 2014). For example, on average, 
200,000 hospitalizations and 36,000 deaths occur annually in the United States due to influenza 
(CDC, 2011). The goal of public health professionals is to concentrate on decreasing the rates of 
hospitalization and deaths due to vaccine-preventable diseases.  
 Currently, there are 17 vaccine-preventable diseases vaccinations (HHS, Healthy People 
2020, 2014). Even though diseases, such as polio, have been eradicated in the United States, does 
not mean children should not be vaccinated against it. All infectious diseases are only a plane 
ride away. A recent example is the rise of measles in the United States. Measles is a highly 
contagious respiratory disease caused by a virus. Measles can spread through the air by coughing 
or sneezing and can lead to a fever, sore throat, and rash covering the body (CDC, 2014a). The 
rates of measles in the United States had been low since the endemic was eradicated in 2000  
  
PREVENTION           4 
 
(Orenstein, Papania & Wharton, 2004); unfortunately, measles cases have been on the rise. 
Currently, the CDC (2014a) has confirmed 603 cases of measles and 20 outbreaks this past year 
– the most number of confirmed cases since 1994. Measles can spread when members of 
communities are not vaccinated.  
 The best way for populations to be protected against infectious diseases is to be fully 
vaccinated. However, more and more individuals are choosing not to vaccinate themselves or 
their children due to personal belief exemptions (PBEs), fear of side effects, and low rates of 
provider recommendations.  
Background 
There was a time when families could not afford vaccines. In the early 1990s, racial and 
ethnic minority children were at a greater risk for measles (Walker, Smith & Kolasa, 2014). In 
order to address the gaps of vaccination coverage, the Vaccines for Children (VFC) Program was 
established in 1994 (The Childhood Immunization Initiative, 2000). VFC is a program managed 
by the CDC and has provided vaccines to children at no cost who might not be vaccinated due to 
their inability to pay (Walker, Smith & Kolasa, 2014). Disparities in vaccination coverage 
amongst racial and ethnic minorities have declined; the VFC program continues to provide 
access to vaccinations to protect all children in the United States from vaccine-preventable 
diseases (Walker, Smith & Kolasa, 2014).  
 In the 1980s, children were not vaccinated because parents and guardians could not 
afford the cost of vaccines. Today, many affluent parents and guardians are refusing to vaccinate 
their children in the state of California (Khazan, 2014). Parents and guardians are submitting 
PBE forms to schools and opting out of vaccinating their child because the vaccines are against  
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their personal beliefs (Allen-Price & Aliferis, 2014). PBE rates have doubled in the last 7 years 
in the state of California (Allen-Price & Aliferis, 2014). This leads to elite counties such as 
Marin, Los Angeles, Santa Monica, and Beverly Hills, to have lower rates of vaccinations and 
higher rates of vaccine-preventable diseases such as whooping cough and measles (Appendix A; 
Khazan, 2014).  
 Since several parents and guardians are opting out of vaccinating their child, herd 
immunity is being impacted (Khazan, 2014). When large proportions of community members are 
vaccinated against infectious diseases, other members of the community are protected against the 
disease because there is a smaller chance of an outbreak through what is coined, herd immunity 
(CDC, 2013). Those individuals who may be ineligible for certain vaccines – pregnant women, 
infants and immunocomprised individuals – are in turn protected because there is a lower risk of 
outbreaks (Appendix B; “Community Immunity,” 2013). Since many counties have lower 
numbers of vaccinations, parents are not only negatively impacting their child’s health; they are 
risking the health of everyone in their community.  
 Other reasons why families do not vaccinate their children is due to safety concerns 
regarding vaccinations. Parents are fearful of the adverse effects of immunization. In a survey 
conducted for the National Consumers League, 1 in 3 parents continue to worry vaccines cause 
autism (Yang, 2014). Despite indisputable evidence regarding vaccines not having a relationship 
with autism, some parents continue to believe there is a positive relationship between vaccinating 
their child and developing autism (Gupta, 2010). Parents who choose not to vaccinate their 
children due to the fear of adverse side effects have different vaccine knowledge compared to 
those parents who choose to vaccinate (Kennedy, Basket, & Sheedy, 2011).  
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Health care providers influence parental vaccination decisions. More than 90% of parents 
state they receive vaccine information from their child’s health care provider (Mergler et al., 
2013). Parents trust their health care providers regarding vaccine safety. Providers are the best 
source of information for parents regarding the importance of vaccinating their children and the 
benefits of full immunization (Grabowsky, Orenstein, & Marcuse, 1996). For many 
recommended vaccines, such as the Human Papillomavirus (HPV) vaccine, there are many 
missed opportunities of provider recommendation for parents of preteen boys and girls 
(Vadaparampil et al., 2011).   
 Each year, the Information and Education section of the Immunization Branch at the 
California Department of Public Health (CDPH) concentrates on increasing immunization rates 
in the state of California. This year, the focus of the CDPH is increasing the immunization rate of 
HPV among boys and girls. HPV is a common virus in the United States – so common that most 
sexually-active men and women will be diagnosed with one type of HPV at some point in their 
lifetime (California Department of Public Health [CDPH], 2014).  Currently, about 79 million 
people are infected with HPV and about 14 million more will become infected every year. Each 
year in the United States, roughly 19,000 women and 8,000 men develop HPV-related cancers 
(CDC, 2014a). HPV causes cancers of the cervix, vulva, and vagina in women and causes cancer 
of the penis in men. HPV can also cause oropharyngeal cancer in both men and women (CDC, 
2014b). There are no routine screening methods for HPV-related cancers for men and the only 
method available for women is during routine PAP smears and testing for HPV infection. The 
HPV vaccine prevents most HPV-related cancers (CDPH, 2014).  
  
  
PREVENTION           7 
 
In a recent study, researchers indicated that vaccine-type HPV prevalence has dropped by 
56% among 14-19 year old females since the vaccine was introduced in 2006 (Markowitz et al., 
2013).  Even though the HPV vaccine is effective and safe, the immunization rates remain low 
for adolescents and adults. In 2013, 68% of teen girls in the state of California received ≥1 dose 
of HPV vaccine, but only 46% of the teen girls and only 17% of teen boys had completed the 
three-dose series (CDC, 2014b). In the same study, vaccination coverage of one dose of the Tdap 
vaccine reached 91%; rates of the HPV vaccination would be identical if adolescents received 
the HPV vaccine at every given opportunity (Appendix C; Stokley et al., 2014). Missed 
vaccinations signify vulnerability to potential HPV-related cancers for preteen boys and girls 
(CDPH, 2014). 
 The CDPH celebrates an annual statewide observance called Preteen Vaccine Week in 
the month of February. During this week, the CDPH works with local health departments, 
schools, local organizations, immunization coalitions, and primary care providers to increase 
awareness of adolescent immunizations and to schedule preteen doctor visits for adolescents to 
be immunized against HPV, Tdap (tetanus, diphtheria, whooping cough), meningococcal, 
influenza, and second dose of the chickenpox vaccine (CDPH, 2014). With the collaboration of 
statewide organizations, the mission of the Information and Education section is to prevent 
disease and death due to vaccine-preventable diseases.  
 The Information and Education section created a Toolkit for Preteen Vaccine Week 2015 
which can be found at the link provided. In the Toolkit, state organizations and health care 
providers are supplied various tools such as: talking points, media alerts, various print materials, 
and activities for organizations to utilize to promote preteen vaccines, especially the HPV  
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vaccine. The Toolkit provides organizations around the state with helpful materials regarding 
increasing the immunization rates against all Advisory Committee on Immunization Practices 
(ACIP) recommendations. The Information and Education section conducts monthly planning 
calls with all local health departments and immunization coalitions regarding the Preteen 
Vaccine Week campaign and addresses all concerns and issues that may arise during the 
planning calls.  
 The Information and Education section has also developed a Tdap prescription pad (see 
Appendix D) in order to vaccinate all women in their third trimester of pregnancy against 
whooping cough. In California, children less than 3 months of age have the highest rate of 
pertussis-related complications and mortality than other age groups. These infants are too young 
to have completed the primary series of pertussis vaccine, and many are too young to have 
received one dose of vaccine (CDC, 2014c). Prior studies indicate that parents, most often the 
mother, are a common source of pertussis infection to young infants. ACIP and the American 
College of Obstetricians and Gynecologists (ACOG) recommend that all women be vaccinated 
with pertussis-containing vaccine (Tdap) during the third trimester of every pregnancy. 
Currently, in the state of California, estimates of uptake of Tdap vaccine among pregnant women 
are below 30% (CDC, 2014d). The approach of shielding infants from pertussis by vaccinating 
those individuals in close contact to the infant is known as cocooning. ACIP recommends 
cocooning along with maternal Tdap vaccination and childhood DTaP series to best protect 
infants from pertussis. However, full cocooning is a challenge so maternal vaccination of Tdap is 
the best chance of protecting infants from pertussis (CDC, 2014e). 
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 The goal of this evaluation is to assess the impact of a written vaccine recommendation 
on pertussis immunization receipt by comparing the immunization rates of third trimester 
pregnant women in the intervention group using the written recommendation against a control 
group using only a verbal recommendation or historic data. The evaluation is currently in 
progress, and the CDPH plans to use the findings to determine continued use of the Tdap 
prescription pad and inform future development of other materials. Results may be shared with 
other statewide partners to help promote the use of the Tdap prescription pad currently being 
evaluated. If the pad is proven effective in increasing pertussis immunization rates among 
pregnant women, all OB/GYN providers will be provided with prescription pads to recommend 
Tdap vaccine in California. 
 The Information and Education section continues working on various campaigns in hopes 
of increasing all vaccination rates in California. Another campaign the section is currently 
working on is called Vaccinate Before You Graduate, where parent letters and educational flyers 
have been developed for graduating 8th graders and high school seniors. The materials recently 
underwent pre- and post-tests to check the efficacy of the message presented and whether the 
educational flyers were informative and helpful. Based on the results of the tests, the Information 
and Education section will modify the materials and make the materials available on the 
California School Nurse Organization (CSNO) website and to all middle and high schools in 
California.  
 The success of all the informational and educational materials the CDPH presents is 
measured through annual studies that are conducted regarding vaccination rates, and information 
presented through the California Immunization Registry (CAIR). CAIR allows providers storage  
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of accurate and confidential information related to immunizations. The registry also helps CDPH 
keep track of immunization rates in different regions, target at-risk populations, and can 
categorize which vaccines need higher uptake. CAIR helps the Information and Education 
section evaluate campaigns and programs they develop by keeping track of who is being 
immunized and with which vaccines.   
Implementation of the project/methods used 
The mission of the fieldwork experience was to assist the Information and Education 
section develop materials that can help increase the vaccination rates in the state of California. 
This fieldwork practice required the development of educational and informational materials for 
statewide organizations, maintain communication with local health departments and primary care 
providers, and raise awareness of vaccine-preventable diseases through novel channels, such as 
social media messages.  The following section of the paper discusses the four goals and learning 
objectives of this fieldwork experience.  
Methods  
General Familiarization with the Immunization Branch of the CDPH 
 It is important to learn the daily activities of the Information and Education section and 
learn the different roles of each staff member. This objective was achieved through the 
completion of the orientation training and reviewing all websites and materials of the 
Immunization Branch.  
Another objective was to observe how the Information and Education section develops 
training, education and communication to providers, the general public, local health departments, 
partner organizations, and schools, and become a contributing member. This objective was  
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achieved by collaborating with various staff members as materials are designed, tested, revised, 
and sent through the approvals process. Through participation with team members, campaign 
materials were discussed, revised, and tested as required. All developed materials must gain 
approval from the entire team before becoming available to statewide organizations. 
The third objective for this goal was to expand the knowledge of public health topics. 
This was achieved by attending CDPH-Richmond lectures as well as webinars and 
familiarization of federal and state immunization programs and policies.  
Participate in the planning of Preteen Vaccine Week Campaign 2015 
 This goal was achieved by learning principles of social marketing campaigns through 
participating in planning, design, implementation and evaluation of statewide campaign. By 
working alongside Jane Pezua, MPH, the Health Educator and lead developer of the Preteen 
Vaccine Week 2015 campaign, campaign materials focusing on the HPV vaccine were 
developed and published on the CDPH website so all organizations in California could access the 
materials.  
Another objective was to assist in the execution of statewide planning calls regarding 
Preteen Vaccine Week. This objective was met by participating in planning stages and execution 
of statewide conference calls. Every month, planning calls are conducted with local health 
departments and immunization coalitions. Prior to all conference calls, planning call slides must 
be created with agenda discussing relevant topics and must be e-mailed on the Monday before 
the call (see Appendix E for web link for example slides). During all planning calls, participants 
were listed by their name and the county they were calling from, and accurate notes and 
questions were recorded to be addressed on the following planning call.  
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The next objective was to prepare promotional materials to accompany the campaign. 
This objective was completed by tracking and evaluating materials created. The materials 
developed were: online and print materials, E-blasts, template materials and new media. 
PowerPoint presentations were created and presented on the importance of using URL shortners 
(Bit.ly and Bit.do) and social media sites to promote vaccinations. Trending Facebook and 
Twitter messages were also developed and approved for health care providers and parents to post 
and promote Preteen Vaccine Week (see Appendix F for approved social media messages).  
Conduct Impact Evaluation on Educational Material  
 To achieve this goal, the objective of learning how the Immunization Branch responds to 
vaccine preventable disease-epidemics (pertussis) and outbreaks must be achieved. To achieve 
this objective, it was important to review data, publications, and materials relevant to 
Immunization Branch’s tracking of and response to pertussis epidemic in 2014. Different 
materials were evaluated from the CDC and ACOG regarding the pertussis epidemic in 
California. Studies conducted on the pertussis epidemic were reviewed to learn how to better 
promote stronger uptake of the Tdap vaccine.  
 Additionally, an objective to coordinate with other interns and Immunization Branch staff 
on a project testing the impact of a recently developed Information and Education material was 
also developed. The Information and Education section developed and tested a prescription pad 
of the Tdap vaccine to increase vaccination rates of third trimester pregnant women. An 
application was submitted for approval to the Institutional Review Board (IRB) and evaluation 
model and methodology was created (see Appendix G). In order to test the prescription pad with  
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health care providers, participants had to be recruited in the state of California. This was done by 
finding all OB/GYNs in the state of California and calling them to see if they vaccinated for 
Tdap on site. If the OB/GYN provider does not vaccinate on the site, they were provided with 
information regarding the study and asked to participate. If the provider agreed, packets with 
instructions, prescription pads and tracking methods were mailed to their office. Qualitative 
surveys were created for the comparison groups for a more thorough study.  
Participate in Maintenance of a To Be Determined Immunization Informing Campaign 
 This goal was achieved by fulfilling the objective of assisting another team member in 
the design and promotion of materials promoting immunization. Different educational materials 
such as flyers and parent letters were created related to the promotion of immunization. The 
materials for the Vaccinate Before You Graduate Campaign were outdated, thus new and 
updated versions were developed (see Appendix H). The materials were tested with graduating 
8th graders and high school seniors to test efficacy and layout of the materials. The pre- and post-
tests were developed and presented to participants in community settings (see Appendix I). The 
results were presented to the team and revisions of the materials were done as required. The final 
materials will be posted on the CSNO website and provided to middle schools and high schools 
throughout California once final approval is received.  
Results/Findings 
 The CDPH is an established governmental agency, and the Immunization Branch is 
dedicated to improving the rates of immunizations for all individuals in California. The 
Information and Education section begins planning for all of the campaigns months in advance. 
The staff of the Information and Education section maintains communications via phone and e- 
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mail with members from the CDC, health care providers, and organizational partners throughout 
the campaign planning. All questions regarding campaign materials and how to best promote 
vaccinations are addressed by the Information and Education section. The Information and 
Education section maintains close relationships with all of the partners because combating 
vaccine-preventable diseases is a group effort.  
The campaigns developed through the Information and Education section are successful 
because they have one aim: to decrease vaccine-preventable diseases by increasing immunization 
rates in statewide. The materials developed are available for everyone to utilize on the CDPH 
website and local health agencies can order mass quantities of print materials for no charge. 
Materials are developed with cultural and racial variations in mind. Many of the materials 
developed by the Information and Education section are translated in Spanish and appropriate 
web links are provided on the CDPH website to route individuals from different cultures to 
appropriate vaccine-related information.  
The Tdap prescription pad evaluation is currently underway so the results are not yet 
available. However, through follow-up phone calls and surveys conducted with participating 
providers, OB/GYNs provided positive feedbacks regarding increased vaccination rates of third 
trimester pregnant women in their respective clinics. After checking in with providers on how 
the study is going and whether or not they like utilizing the prescription pad when 
recommending the Tdap vaccine to their patients, all of the participating OB/GYNs have stated 
that the prescription pads are more effective in recommending the Tdap vaccine to patients than 
verbal recommendations alone.  
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Application of Results/Public Health Significance 
 Having a governmental organization partner with local health departments and other 
organizations within the state to address vaccination rates is a significant public health project. 
Through the development of campaigns and creating Toolkits to help organization increase rates 
of vaccinations provides local organizations with guidance of how to better improve vaccination 
rates in the state. Vaccines have been proven to save lives, but due to confounding factors the 
rates of vaccinations have decreased. By having governmental support from agencies like the 
CDPH, providers can be educated on how to stress the importance of recommended vaccines and 
local agencies can help educate community members on vaccine safety and regarding the 
protection vaccines can provide against deadly communicable diseases.  
 It is rewarding to ask representatives from all the different counties in California 
regarding what information and materials they need to help increase the rates of vaccinations in 
their specific counties. Through the monthly planning calls, members of the different counties 
are able to request specific educational materials for their counties. For instance, through the 
planning calls, members of the Information and Education section were asked to provide a guest 
speaker from the CDC to discuss evaluation methods of activities on one of the scheduled 
planning calls. Since this was something all participating counties expressed interest in, the 
CDPH was able to have two members from the CDC talk about campaign evaluation methods 
and metrics (see Appendix J for web link).  
 Through communicating with immunization coordinators throughout the state, the CDPH 
is able to keep track of what the different counties are doing to increase the rates of 
immunization in their communities. The campaigns have helped increase awareness of  
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immunization in many communities of California, and through the development of different 
educational materials, further awareness can spread. 
Competencies Addressed 
 The fieldwork experience has allowed for the incorporation of classroom knowledge to 
be applied to real-life public health settings combating real-life public health problems. Through 
the fieldwork practice, experience was gained on how to assess the need of communities, 
distinguishing stakeholders, creating innovative ways to increase awareness of the public health 
problem, and how to track and evaluate measures that are developed to address the problem. The 
fieldwork experience has also helped strengthen communication skills between partners to 
address the problem and to develop a solution.  
 Through this fieldwork experience, University of San Francisco (USF) MPH core 
competencies and cross-cutting competencies were utilized (see appendix K). Since the goal of 
the Information and Education section is to increase the rates of vaccinations among community 
members, social and behavioral science core competency was greatly addressed through this 
experience because vaccine uptake depends on factors within individuals and communities. 
Campaigns and materials are developed to help educate community members regarding the 
importance of full vaccination at the individual and community levels. Different activities are 
also provided in the Preteen Vaccine Week 2015 Toolkit to help members of the community 
become more informed on the importance of being vaccinated against all vaccine-preventable 
diseases.  
The core competencies of biostatistics and epidemiology were applied when developing 
the Tdap prescription pad evaluation study and surveys to increase the Tdap vaccination rates of  
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third trimester pregnant women. Data is in the process of being collected and evaluated to 
determine whether the created Information and Education material increases Tdap vaccine 
uptake. Epidemiology was addressed when monitoring the distribution of decreased vaccination 
rates in certain counties of California. Through research, CDPH has a better understanding of 
which communities are submitting greater PBEs and where immunization rates remain low.  
 The environmental health science core knowledge was applied when creating educational 
materials in regards to community and social organizations. In reference to the Tdap prescription 
pad evaluation, in order for the study to be effective, it was important to find OB/GYN providers 
that do not vaccinate for Tdap on site.  
 One of the important core knowledge that has been shaped and improved throughout the 
experience is leadership skills and abilities. For many of the materials developed, the fieldwork 
experience provided ample opportunities to step into leadership position and take charge. When 
developing and presenting PowerPoint presentations on social media and URL shortners, 
creating evaluation plan for the Tdap prescription pad study, submitting documents for approval, 
developing certain materials and activities for Preteen Vaccine Week campaign Toolkit, and 
updating versions for the Vaccinate Before You Graduate educational materials, all leadership 
responsibilities were handed over with minimal supervision. 
 Along with these core competencies, cross-cutting knowledge areas were also addressed. 
The cross-cutting knowledge of health communication and informatics are essential for the 
promotion and education of vaccinations. Through effective communication and development of  
appropriate health materials, public health professionals are able to change the health beliefs and 
behaviors regarding immunization in the communities. Through developing educational  
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materials targeted to specific groups of individuals, such as social media messages geared 
towards parents and teenagers, community members can help spread awareness of the 
importance of being fully vaccinated to other individuals in their social networks.  
 Program planning is another cross-cutting knowledge that was addressed during this 
fieldwork experience. Through determining the needs, planning the materials, and creating an 
evaluation plan, appropriate materials are created to address the public health problem. For 
instance, since there is a pertussis epidemic in the state of California this year, the need was 
addressed by creating a prescription pad providers can use when recommending the Tdap 
vaccine to pregnant women in their third trimester of pregnancy. A full evaluation plan was 
developed to see whether the prescription pad is effective in increasing vaccination rates among 
target population. Providers were recruited based on the requirement of not vaccinating on site 
and appropriate materials were sent to the providers to conduct the evaluation.  
 The final cross-cutting knowledge that was widely addressed was diversity and culture. 
Most of the campaign materials that are developed keep cultural beliefs and attitudes in mind. 
Most of the materials are also translated into Spanish to help raise awareness of vaccine-
preventable diseases in the Hispanic communities of California. The CDPH website has also  
been recently updated to direct different ethnic minorities to culturally appropriate websites 
regarding vaccine safety information.  
 The USF MPH program has provided adequate coursework for this fieldwork experience 
to be successful. The professors have taught the students to determine the needs of the 
community while keeping moral and ethical values in mind. By providing classes focused on 
core knowledge areas, students are prepared to enter real public health settings ready to address  
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any public health problem. For this fieldwork experience, biostatistics helped develop surveys 
and interpret health data, epidemiology helped understand the characteristics of human 
population and distribution of vaccination rates, environmental health sciences helped look at 
community and social structures, social and behavioral sciences helped develop appropriate 
educational materials, and leadership helped build confidence in addressing the public health 
need.  
Conclusions 
 This fieldwork experience was extremely enriching and provided immense knowledge of 
how to address vital public health problems such as increasing immunization rates in the United 
States. The fieldwork was a great experience because it went hand-in-hand with the USF MPH 
program. All of the information learned in the classroom was applied in developing materials for 
the Information and Education section. 
 The projects assigned during the fieldwork have helped develop skills such as 
communicating and networking with other members to meet a common goal, not being afraid to 
ask questions or request clarifications when things may seem unsure, and not being afraid to step  
into leadership positions. None of this would have been possible without the support and trust 
from the preceptor, Jane Pezua, MPH.  
 Jane has always been approachable and understanding. She assigned work with 
confidence and was always available to help if things were unclear. The fieldwork experience 
has helped develop skills and insights of working in the governmental sector of a public health  
setting. The combination of courses offered within the MPH program at USF and the public 
health fieldwork practice have provided with great experience in understanding a great public  
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health need, learning how to build relationships with team members and members of the 
community, and developing and evaluating appropriate materials to combat a public health 
problem.  
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Appendices  
 
Appendix A 
 
 
 
This is a map of schools in Santa Monica. The red dots signify schools with severely low rates of 
vaccinations.  
  
Appendix B 
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Appendix C 
 
 
 
Appendix D 
 
 
 
Appendix E 
 
Please visit the CDPH Preteen Vaccine Week page (http://bit.do/PlanningSlides) for example of 
planning slides created before each planning call. 
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Appendix F 
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Appendix G 
Evaluating the effectiveness of a written vaccine recommendation in 
improving immunization rates against pertussis in third trimester pregnant 
women: Evaluation plan for October – November 2014 
Prepared by: Jane Pezua and Vaisali Patel 
California Department of Public Health – Immunization Branch  
 
Introduction 
In California, children less than three months of age have the highest rate of pertussis-related 
complications and mortality than other age groups. These infants are too young to have 
completed the primary series of pertussis vaccine; many too young to have even received one 
dose of vaccine. 
 
Prior studies have shown parents, most often the mother, are a common source of pertussis 
infection to young infants. The Advisory Committee on Immunization Practices and the 
American College of Obstetricians and Gynecologists recommend that all women be vaccinated 
with pertussis-containing vaccine (Tdap) during the third trimester of each pregnancy, regardless 
of whether they have ever received the vaccine previously; however estimates of uptake of Tdap 
vaccine among pregnant women are low (below 30%). 
 
Evaluation Goals 
The goal of this evaluation is to assess the impact of a written vaccine recommendation on 
pertussis immunization receipt by comparing the immunization rates of third trimester pregnant 
women in the intervention group using the written recommendation against that of the control 
group using only a verbal recommendation/historic data. We plan to use the findings to 
determine continued use of the material being evaluated and inform future development of other 
materials. Results may be shared with other state partners to help promote the use of the material 
being evaluated if proven effective at increasing pertussis immunization rates among pregnant 
women. 
 
Evaluation Team 
Our team consists of members of the Immunization Branch at the California Department of 
Public Health.  
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Table 1. Roles and responsibilities of the evaluation team members  
Individual Title/Role Responsibility 
Jane Pezua  Principal Investigator (PI)   • Application for 
Determination for Exempt 
Research to CPHS 
• Recruitment  
• Training  
• Qualitative survey design 
and analysis 
• Packaging and mailing of 
participant packets  
• Data Collection  
• Consultation with 
EHR/EMR representatives 
• Screening of evaluation 
study participant 
applicants   
• Oversight of all evaluation 
activities to ensure the 
evaluation is conducted as 
planned 
• Coordinate team meetings 
• Presentation of findings  
Vaisali Patel  Research Coordinator (RC) • Application for 
Determination for Exempt 
Research to CPHS  
• Recruitment 
• Packaging and mailing of 
participants packets  
• Data Collection 
• Analyze quantitative data  
• Ensure implementation of 
findings 
Steven Smith  Research Coordinator (RC) • Data collection  
• Analyze quantitative data 
• Coordinate the analysis of 
qualitative data  
• Ensure implementation of 
findings 
 
 
I. BACKGROUND AND DESCRIPTION OF THE IMPACT STUDY AND LOGIC 
MODEL  
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Need 
A pertussis epidemic has been declared in the state of California in 2014. Pertussis infection 
acquired within the first 3 months of life is frequently severe and fatal. Recently, three infants 
have died and many more have been hospitalized. Previous studies have found mothers to be a 
common source of pertussis infection in young infants. With a pertussis epidemic declared and 
evidence of waning immunity within two years after vaccination with Tdap, immunization of 
pregnant women is disappointingly uncommon: a survey of women delivering in California 
hospitals in October 2013 indicated that only 20-25% received Tdap during pregnancy. Prenatal 
care providers play an important role in preventing additional infant deaths due to pertussis.  
 
As a standard of care, ACOG, ACNM, CDC, and CDPH strongly recommend that all pregnant 
women receive Tdap vaccine between 27 and 36 weeks gestation during every pregnancy, 
regardless of the number of doses of Tdap they have previously received. Of the infant pertussis 
cases reported so far this year (including fatal and hospitalized cases), at least 91% of their 
mothers had not received Tdap at the optimal time.   
 
Target Population  
The target population for this impact study is pregnant women who were seen by an obstetrician 
at a participating practice during the third trimester of pregnancy, however only aggregated totals 
of the number of patients presenting for a third trimester appointment and number reporting 
receipt of Tdap vaccine on a follow-up visit will be reported to CDPH. 
 
Objectives 
 
The goal of providing prenatal care providers with a Tdap prescription pad is to help providers 
communicate a strong recommendation to pregnant women thereby increasing the number of 
women receiving the Tdap vaccination during their third trimester of pregnancy. In order to 
achieve this overarching goal, objectives were identified for the impact study.  
 
1. There will be an increase of Tdap immunization rates in the intervention group compared 
to the control group. 
 
2. More women in their 3rd trimester of pregnancy will receive the Tdap vaccine compared 
to baseline data.  
 
3. 50% of OB providers will agree the Tdap prescription pad aided them in providing a 
strong recommendation for women to receive the Tdap vaccine in their 3rd trimester of 
pregnancy.  
 
Stage of Development  
 
The Tdap prescription pad was developed by the Immunization Branch in 2014. It has been made 
available to providers for use in August, 2014.  
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Resources/Inputs 
 
Immunization Branch staff and interns (Principal Investigator and two Research Coordinators), 
OB physicians, nurses, MAs, office managers, third trimester pregnant women, EHR/EMR 
systems and data, Tdap prescription pad, EHR system representative, funds for distribution of 
mailers, Tap vaccine, and qualitative surveys of OBs. 
  
Outputs  
 
Print supply of Tdap prescription pads for participating OBs, training of relevant staff at 
participating clinics, prescribing of Tdap using the Tdap prescription pad by OBs for 3rd 
trimester pregnant women, receipt of Tdap by 3rd trimester pregnant women, reporting of 
EHR/EMR generated data to PI and RCs, analysis of aggregate data, completion of qualitative 
survey by OBs 
 
Outcomes 
 
A short outcome is to emphasize importance of Tdap in 3rd trimester pregnant women to OBs. 
Intermediate outcomes include: increase vaccination rates of 3rd trimester pregnant women and 
use evaluation results to determine future promotion of Tdap prescription pad by CDPH. Long 
term outcomes include: decrease incidence of pertussis infection in mothers of infants too young 
to be vaccinated, decrease incidence of pertussis infection in infants too young to be vaccinated, 
and improve effectiveness of Tdap recommendation by OBs to 3rd trimester pregnant women.  
 
Logic Model 
 
Please refer to the Logic Model at the end of the document.  
 
II. FOCUS OF EVALUATION 
 
Evaluation questions  
 
Although the evaluation team produced many questions in a brainstorming session, the 
evaluation team arranged the following questions as representing the most important for this 
impact study. 
 
To determine if the intervention has been implemented as planned: 
 
• Have an appropriate number of OB providers been recruited to participate in this study? 
 
 
To determine if the study is meeting its objectives: 
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• Are OB providers adhering to the utilization of the Tdap prescription pad when 
consulting with women in their third trimester of pregnancy? 
 
• Are OB providers stressing the importance of being vaccinated with Tdap in the third 
trimester of pregnancy to prevent pertussis infection in infants?  
 
Evaluation Design 
 
Intervention/control group; analysis of aggregate data. OR intervention group; analysis of pre 
and post-intervention data. 
 
III. GATHERING CREDIBLE EVIDENCE: DATA COLLECTION 
 
Data Collection 
 
The evaluation utilizes the following data collection: quantitative aggregate data from 
EHR/EMR generated reports on number of third trimester women seen by participating OB 
providers and number who later receive Tdap vaccine and qualitative survey administered to 
participating OB providers via internet survey (i.e., SurveyMonkey).Table 2 summarizes the data 
source and data collection methodology that will be used to gather evidence for the evaluation.  
 
Table 2. Data Collection Plan  
 
Indicator Data Source Data Collection Method 
Number of women who 
received the Tdap vaccine 
after receiving a prescription 
Aggregate data from 
EHR/EMR system generated 
reports 
Review submitted reports 
from participating OB 
providers on Tdap 
immunization of 3rd trimester 
pregnant women 
• Jane Pezua and Vaisali 
Patel  
• TBA 
Qualitative survey 
administered to OB providers 
Internet survey 
(SurveyMonkey) 
Review questions asked and 
responses received from 
participants 
• Jane Pezua & Vaisali 
Patel 
• TBA 
 
Plan Timeline  
 
Table 3. Illustrative Timeline for Evaluation Activities  
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Evaluation Activities Timing of Activities for Sep. – Dec. 2014 
Sep Oct Nov Dec 
Evaluation planning +       
Data collection   +  +   
Analysis/interpretation     +   
Report/dissemination       + 
 
IV. JUSTIFY CONCLUSIONS: ANALYSIS AND INTERPRETATION  
 
Analysis 
 
We will conduct an observational study to compare the frequency of immunization receipt in the 
group offered the prescription pads and the group given only verbal recommendation to 
vaccinate. We will use Statistical Analysis System to examine the bivariate relationship between 
the two groups.  Categorical data will be analyzed for significance using a Chi-square test and 
Fisher’s exact test. 
 
It is important to remember that data from all observational studies require attention to reduce 
possibility of bias and confounding, given self-selection for vaccination and the influence of 
health-seeking behavior. 
 
Table 4. Analysis Plan 
 
Data Analysis Technique Responsible Person 
Quantitative – frequency/counts Jane Pezua and Vaisali Patel 
Qualitative – content analysis Jane Pezua, Vaisali Patel and 
Steven Smith  
 
Interpretation  
 
The PI and the two RCs will be in charge of interpreting the findings. The data from the 
evaluation will be compared to the statewide average rates of 3rd trimester women who receive 
the Tdap vaccine.  
 
V. ENSURE USE AND SHARE INFORMATION: REPORT AND DISSEMINATION 
Dissemination  
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Evaluation findings will be disseminated through various routes. Findings will be presented to 
the Health Educator Supervisor and Chief of the Information and Education Section of the 
Immunization Branch. A summary of findings will be published in the quarterly Immunization 
Branch newsletter. The report will be available to the Information and Education staff, different 
sections of the Immunization Branch, and participating practices and physicians.  
 
Table 5. Dissemination Plan 
Dissemination Medium Responsible Person 
Presentation to Health Educator Supervisor and 
Section Chief, Information and Education 
Section, Immunization Branch, CDPH 
Jane Pezua  
Report of findings provided to the Information 
and Education staff, different sections of the 
Immunization Branch, and participating 
practices and physicians  
Jane Pezua, Vaisali Patel, and Steven 
Smith  
Article in quarterly Immunization Branch 
Newsletter  
Jane Pezua and Vaisali Patel 
 
Use  
 
The findings from this study will help the Immunization Branch at the CDPH understand how to 
better campaign for Tdap immunization of 3rd trimester pregnant women. OB providers will use 
the finding to improve patient adherence to recommended vaccinations. Providers will see an 
increase in Tdap immunization rates and will use the prescription pad strategy as a means for 
effective recommendation of the vaccine. Ultimately, the findings from this evaluation will be 
used for future evaluations.  
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LOGIC MODEL 
 
Program:   Evaluating the effectiveness of a written vaccine recommendation in improving immunization rates against 
pertussis in third trimester pregnant women  
Situation: Statewide efforts to prevent pertussis infection in infants during pertussis epidemic 
 
 
Inputs  Outputs  Outcomes -- Impact 
 Activities Participation 
 
Short Medium Long 
• IZ Branch staff and 
interns (PI, 2 RCs) 
• OB physicians, 
nurses/MAs, office 
managers 
• 3rd trimester 
pregnant women 
• EHR/EMR systems 
and data 
• Tdap prescription 
pad 
• EHR system 
representative 
• Funds for distribution 
of mailers 
• Tdap vaccine 
• Qualitative survey of 
OBs 
 • Print supply of Tdap 
prescription pads for 
participating OBs 
• Training of relevant 
staff at participating 
clinics 
• Prescribing of Tdap 
using the Tdap 
prescription pad by 
OBs for 3rd trimester 
pregnant women 
• Receipt of Tdap by 
3rd trimester 
pregnant women 
• Reporting of 
EHR/EMR 
generated data to PI 
and RCs 
• Analysis of 
aggregate data 
• Completion of 
qualitative survey by 
OBs 
 
• 3rd trimester women 
• OB physicians 
• Nurses/MAs 
• Office managers 
 
 • Emphasize 
importance of Tdap 
in 3rd trimester 
pregnant women to 
OBs 
 
• Increase vaccination 
rates of 3rd trimester 
pregnant women 
• Use evaluation 
results to determine 
future promotion of 
Tdap prescription 
pad by CDPH 
• Decrease incidence 
of pertussis 
infection in mothers 
of infants too young 
to be vaccinated 
• Decrease incidence 
of pertussis 
infection in infants 
too young to be 
vaccinated 
• Improve 
effectiveness of 
Tdap 
recommendation by 
OBs to 3rd trimester 
pregnant women 
Assumptions 
 
External Factors 
Utilization of Tdap prescription pad by OBs with 3rd trimester pregnant women will result 
in higher immunization rates than a verbal recommendation alone. 
OBs will provide Tdap prescription to every 3rd trimester pregnant woman seen during 
intervention period. 
 
Inconsistent use of Tdap prescription pad 
Influence of media coverage of pertussis epidemic on 3rd trimester pregnant women’s 
decision to get vaccinated 
Loss of Tdap prescription by 3rd trimester pregnant woman 
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Appendix F 
 
 
 
 
 
 
 
 
Updated high school flyer      Updated 8th grade flyer  
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Appendix I 
 
Background Questionnaire 
 
Your initials: ________       Date_________   
 
Please answer all of the questions below. Your answers are confidential and will be used for 
research purposes only. Your initials will not appear in any reports. 
 
1. What is your age?   __________      
 
 
2. Your gender?   Male   Female 
 
 
3. What best describes your racial/ethnic identity?      
 White (Non-Latino)                        Asian            
 Black      Latino               
 Pacific Islander    Mixed Race   
 Other________________ 
 
 
4. How much do you agree with the following statement? Vaccines are safe and effective. 
 Strongly agree      Agree      Neutral      Disagree      Strongly disagree 
 
 
5. Which of the following shots are recommended before you graduate? 
 Tdap                Meningococcal               Flu              HPV              All of these 
       (whooping cough)                         (human papillomavirus) 
 
 
6. Who do you think is at risk for getting a vaccine-preventable disease?   
 
 
 
7. How much do you agree with the following statement? Do you believe YOU are at risk for 
getting a vaccine-preventable disease?   
 Strongly agree      Agree      Neutral      Disagree      Strongly disagree 
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8. What shots have you received?  
 Tdap              Meningococcal                  HPV              None of these  Not sure 
    (whooping cough)             (human papillomavirus) 
 
 
                                      
9. What have you heard about any of these shots? 
 
 
 
10. On a scale of 1 to 5 (1 = not at all important to 5 = critically important)  
      How important do you think it is for you to protect yourself from vaccine-preventable     
      diseases by getting the recommended shots?   
 
1           2          3          4           5            
 Not Important                Critically Important 
 
 
11. On a scale of 1 to 5, (1 = not at all important to 5 = critically important)  
       How likely is it that you will ask your parents/guardians and doctor about getting the          
       recommended shots before you graduate?   
 
1           2          3          4           5          
Not Important                Critically Important           
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Post-Review Questionnaire 
 
Your initials: ________       Date_________   
 
Now that you have read the flyer, Please answer all of the questions below. Your answers are 
confidential and will be used for research purposes only. Your initials will not appear in any 
reports. 
 
1. How much do you agree with the following statement? Vaccines are safe and effective. 
     Strongly agree      Agree      Neutral      Disagree      Strongly disagree 
 
 
2. Who do you think is at risk for getting a vaccine-preventable disease?   
 
 
 
3. How much do you agree with the following statement? Do you believe YOU are at risk for      
    getting a vaccine-preventable disease?   
     Strongly agree    Agree    Neutral    Disagree    Strongly disagree 
       
                              
 
 
4. On a scale of 1 to 5 (1 = not at all important to 5 = critically important)  
     How important do you think it is for you to protect yourself from vaccine-preventable    
     diseases by getting the recommended shots?   
 
1           2          3          4           5         
 Not Important                Critically Important 
 
 
5. On a scale of 1 to 5, (1 = not at all important to 5 = critically important)  
    How likely is it that you will ask your parents/guardians and doctor about getting the      
    recommended shots before you graduate?   
 
1           2          3                4           5          
Not Important                Critically Important           
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Appendix J 
 
Please take a look at the September Planning Call slides (http://bit.do/SeptemberPlanningCall) 
for information regarding evaluation and metrics from guest speakers from the CDC. 
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Appendix K       Student Preceptor Agreement 
Goal 1: General familiarization with the Immunization Branch of the California Department of Public Health (CDPH) 
Objective(s) Activities  Start/End Date Who is Responsible  Tracking Measures  
Learn the daily activities 
of the I&E section and 
the different roles of 
each staff member. 
Complete orientation 
training.  
Review all websites and 
materials of 
Immunization Branch. 
August 25, 2014 – 
September 5, 2014 
Vaisali Patel and Jane 
Pezua 
Jane will give Vaisali a 
rundown on the I&E 
section, introduce 
Vaisali to different staff, 
and provide trainings. 
Observe how the 
Information and 
Education (I&E) section 
develops training, 
education and 
communication to 
providers, the general 
public, local health 
departments, partner 
organizations, and 
schools, and become a 
contributing member.  
Collaborate with various 
staff members as 
materials are designed, 
tested, revised, and sent 
through the approvals 
process. 
Participate in I&E health 
education team 
meetings.  
August 26, 2014 – 
November 26, 2014 
Vasali Patel and Jane 
Pezua  
Jane will include Vaisali 
in all of the meetings 
and assign Vaisali to 
work on specific 
projects. 
Expand knowledge of 
public health related 
topics. 
 
Attend CDPH-
Richmond lectures. 
Familiarization of 
federal and state 
immunization programs 
and policies. 
 
August 25, 2014 – 
November 26, 2014 
Vaisali Patel Vaisali will attend all 
relevant lectures and 
seminars presented at the 
CDPH and will, through 
her assignment to 
various projects, 
research federal and 
state immunization 
programs and the 
vaccine policy process. 
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Goal 2: Goal: Participate in Planning of Preteen Vaccine Week Campaign 2015, an immunization informing campaign 
Objective(s) Activities  Start/End Date Who is Responsible  Tracking Measures  
Learn principles of 
social marketing 
campaigns. 
 
Participate in planning, 
design, implementation 
and evaluation of 
statewide campaign. 
 
August 20, 2014 – 
November 26, 2014 
Vaisali Patel and Jane 
Pezua 
Jane and Vaisali will 
work together to create 
the campaign materials 
for Preteen Vaccine 
Week 2015; focusing on 
the HPV vaccine.  
Assist in the execution 
of statewide planning 
calls. 
 
Participate in planning 
stages and execution of 
statewide conference 
calls.   
August 20, 2014 – 
November 26, 2014 
Vasali Patel and Jane 
Pezua  
Jane will include Vaisali 
in the conference calls.  
Prepare promotional 
materials to accompany 
campaign. 
Track and evaluate 
through materials 
created:  
      Online/print 
materials, E-blasts, 
template materials, new 
media. 
August 26, 2014 – 
November 26, 2014 
Vaisali Patel and Jane 
Pezua  
Vaisali will help Jane 
create educational 
material for Preteen 
Vaccine Week 2015. 
Jane and Vaisali will 
evaluate new materials 
and revise as necessary.  
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Goal 3: Goal: Conduct Impact Evaluation of Education Material 
Objective(s) Activities  Start/End Date Who is Responsible  Tracking Measures  
Learn how the 
Immunization Branch 
responds to vaccine 
preventable disease-
epidemics (pertussis) 
and outbreaks. 
 
Review data, 
publications, and 
materials relevant to 
Immunization Branch’s 
tracking of and response 
to pertussis epidemic 
2014. 
 
September 2, 2014 – 
November 26, 2014 
Vaisali Patel and Jane 
Pezua 
Jane will provide Vaisali 
with data and materials 
to review on the 
pertussis epidemic in 
2014.  
Coordinate with other 
interns and IZ Branch 
Staff on a project testing 
the impact of a recently 
develop I&E material. 
 
Design evaluation model 
and methodology. 
Recruit and train 
participants at health 
clinics. 
 
September 2, 2014 – 
November 26, 2014 
Vasali Patel and Jane 
Pezua  
Vaisali will work with 
Jane to design evaluation 
model and help recruit 
and train participants in 
health clinics in Los 
Angeles county. 
 
Goal 4: Goal: Participate in maintenance of a TBD immunization informing campaign 
Objective(s) Activities  Start/End Date Who is Responsible  Tracking Measures  
Assist in the design and 
promotion of materials 
promoting 
immunization.  
Create educational 
material such as banners 
and posters related to the 
promotion of 
immunization.  
 
September 2, 2014 – 
October 3, 2014 
Rebeca Boyte, MAS 
(Health Education 
Supervisor) and Vaisali 
Patel 
Vaisali will work with 
Rebeca to revise and 
update educational 
material for the assigned 
campaign.   
 
 
 
 
 
